Thyrocare Technologies Stock Screener | Share Price & Fundamental Analysis
THYROCARE
Healthcare Service Provider
Screen Thyrocare Technologies share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹461.90
▲
2.70 (0.59%)
Share Price BSE
₹462.35
▲
3.25 (0.71%)
Market Cap
₹7,124.87 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
13.47
EPS (TTM)
₹17.13
Dividend Yield
1.55%
Debt to Equity
0.06
52W High
₹1591.90
52W Low
₹410.05
Operating Margin
33.00%
Profit Margin
21.82%
Revenue (TTM)
₹220.00
EBITDA
₹75.00
Net Income
₹48.00
Total Assets
₹693.00
Total Equity
₹547.00
Thyrocare Technologies Share Price History - Stock Screener Chart
Screen THYROCARE historical share price movements with interactive charts. Analyze price trends and patterns.
Thyrocare Technologies Company Profile - Fundamental Screener
Screen Thyrocare Technologies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for THYROCARE shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE594H01019
Thyrocare Technologies Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen THYROCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 | 410 |
| Current Assets | 338 | 279 | 273 | 270 | 240 | 152 | 136 | 142 | 150 | 134 |
| Fixed Assets | 297 | 306 | 294 | 285 | 253 | 269 | 294 | 299 | 259 | 259 |
| Liabilities | ||||||||||
| Total Liabilities | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 | 410 |
| Current Liabilities | 24 | 26 | 20 | 17 | 23 | 23 | 19 | 15 | 12 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 547 | 528 | 535 | 527 | 427 | 367 | 435 | 443 | 408 | 366 |
| Share Capital | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 54 | 54 | 54 |
| Reserves & Surplus | 439 | 440 | 463 | 474 | 374 | 314 | 382 | 390 | 354 | 312 |
Screen THYROCARE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 220 | 198 | 192 | 170 | 180 | 161 | 158 | 138 | 151 | 136 | 140 | 131 | 137 | 129 | 133 |
| Expenses | 145 | 135 | 130 | 124 | 129 | 115 | 121 | 103 | 111 | 100 | 111 | 100 | 103 | 92 | 93 |
| EBITDA | 75 | 63 | 62 | 46 | 51 | 46 | 37 | 35 | 40 | 36 | 29 | 31 | 33 | 37 | 40 |
| Operating Profit % | 33.00% | 30.00% | 30.00% | 25.00% | 27.00% | 27.00% | 22.00% | 23.00% | 25.00% | 26.00% | 18.00% | 22.00% | 23.00% | 28.00% | 29.00% |
| Depreciation | 12 | 11 | 14 | 17 | 13 | 11 | 13 | 14 | 11 | 10 | 11 | 10 | 9 | 9 | 10 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 63 | 51 | 47 | 28 | 37 | 34 | 23 | 20 | 28 | 25 | 17 | 20 | 24 | 28 | 30 |
| Tax | 15 | 12 | 26 | 9 | 10 | 10 | 6 | 5 | 8 | 8 | 5 | 5 | 8 | 6 | 9 |
| Net Profit | 48 | 38 | 22 | 19 | 26 | 24 | 17 | 15 | 20 | 17 | 13 | 15 | 15 | 22 | 21 |
| EPS | 9.05 | 7.35 | 4.17 | 3.58 | 4.99 | 4.52 | 3.54 | 2.78 | 3.84 | 3.26 | 2.36 | 2.78 | 3.80 | 4.11 | 4.04 |
Thyrocare Technologies Cash Flow Screener - Liquidity Fundamentals
Screen THYROCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 191 | 168 | 129 | 113 | 115 | 168 | 100 | 107 | 90 | 68 |
| Investing Activities | -53 | -91 | -39 | -24 | -49 | 1 | -12 | -43 | -42 | -18 |
| Financing Activities | -130 | -85 | -86 | -89 | -62 | -165 | -94 | -64 | -49 | -45 |
| Net Cash Flow | 8 | -9 | 4 | 0 | 5 | 4 | -5 | 0 | -1 | 5 |
Screen THYROCARE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.06% | 71.06% | 71.06% | 60.93% | 71.11% | 71.11% | 71.11% | 71.06% |
| FII Holding | 2.41% | 3.23% | 4.85% | 5.32% | 2.90% | 2.49% | 1.93% | 2.77% |
| DII Holding | 14.97% | 14.54% | 13.47% | 20.17% | 14.88% | 14.90% | 14.80% | 14.67% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.21% | 8.94% | 8.19% | 10.79% | 8.48% | 8.66% | 9.78% | 9.16% |
| Other Holding | 2.36% | 2.23% | 2.43% | 2.80% | 2.63% | 2.84% | 2.38% | 2.33% |
| Shareholder Count | 57,403 | 54,566 | 54,142 | 77,969 | 64,823 | 61,636 | 59,377 | 56,666 |
Thyrocare Technologies Dividend Screener - Share Yield Analysis
Screen THYROCARE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹21.00 | 4.64% |
| 2024-March | ₹18.00 | 7.95% |
| 2023-March | ₹18.00 | 9.15% |
| 2022-March | ₹15.00 | 10.47% |
| 2021-March | ₹25.00 | 9.67% |
| 2020-March | ₹5.00 | 1.66% |
| 2019-March | ₹20.00 | 12.08% |
| 2018-March | ₹10.00 | 5.62% |
| 2017-March | ₹10.00 | 5.03% |
| 2016-March | ₹10.00 | 4.18% |
Thyrocare Technologies Index Membership - Market Screener Classification
Screen THYROCARE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Thyrocare Technologies Market Events Screener - Corporate Actions
Screen THYROCARE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-28 | 2025-11-28 | Bonus | 2:1 | -5.76% |
| 2025-10-24 | 2025-10-24 | Dividend | ₹ 7.00 /share | -0.66% |
| 2025-10-14 | 2025-10-14 | Quarterly Result Announcement | NA | 7.05% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | 27.09% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 21.00 /share | 68.16% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | 2.06% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 13.10% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -2.22% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | 7.33% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 8.95% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 18.00 /share | 42.02% |
| 2023-04-20 | 2023-04-20 | Dividend | ₹ 18.00 /share | 13.04% |
| 2022-05-11 | 2022-05-12 | Dividend | ₹ 15.00 /share | -9.36% |
| 2021-06-17 | 2021-06-19 | Dividend | ₹ 15.00 /share | 21.60% |
Thyrocare Technologies Competitors Screener - Peer Comparison
Screen THYROCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,603 | 45.21 | 2,555 | 11.28% | 492 | 48.87 |
| Vijaya Diagnostic Centre | 10,893 | 70.73 | 700 | 23.06% | 144 | 61.17 |
| Metropolis Healthcare | 9,787 | 60.67 | 1,346 | 10.64% | 146 | 37.00 |
| Thyrocare Technologies | 7,125 | 56.80 | 702 | 20.80% | 91 | 50.51 |
| Nephrocare Health Services | 4,675 | 69.33 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,310 | 27.13 | 743 | 16.70% | 78 | 33.52 |
| Suraksha Diagnostic | 1,395 | 44.71 | 256 | 15.11% | 31 | 30.88 |
| One Global Service Provider | 1,222 | 28.19 | 148 | 134.60% | 19 | 60.04 |
| 3B BlackBio DX | 1,184 | 24.82 | 112 | 28.72% | 48 | 59.23 |
| Sastasundar Ventures | 955 | -104.79 | 1,171 | -18.47% | -134 | 43.45 |
Thyrocare Technologies Company Announcements - News Screener
Screen THYROCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-29 | Closure of Trading Window | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-05 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | View |
| 2025-12-05 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | View |
| 2025-12-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-03 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-16 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-16 | Corporate Action - Fixes Record Date For Bonus Issue | View |
| 2025-11-16 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-16 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-14 | Clarification On Significant Movement In Volume Of Shares Of The Company | View |
| 2025-11-14 | Clarification sought from Thyrocare Technologies Ltd | - |
| 2025-11-12 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | View |
| 2025-10-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-27 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-24 | Disclosure Of Sale Of 5332860 Equity Shares (Approximately 10% Stake) By Promoter - Docon Technologies Private Limited | View |